Read More

Microsoft To Unveil New Surface Devices At Redmond Event

Microsoft Corp. (NASDAQ: MSFT) is set to unveil new Surface Pro and Surface Laptop models featuring Qualcomm Inc (NASDAQ: QCOM) Snapdragon X Elite chips with advanced AI capabilities. This significant shift from Intel processors highlights Microsoft's commitment to AI-driven consumer devices. The announcement precedes the annual developer conference, aiming to strengthen Microsoft's position in the competitive AI tools market, especially against rivals like Apple and Google.

AAPL

Read More

Tesla Layoffs To Continue Through June, Morale Low Among Workers

Tesla Inc. (NASDAQ: TSLA) employees live in fear as layoffs continue through June. CEO Elon Musk's plan to cut at least 10% of the workforce has left employees anxious, uncertain of their job security. Former sales representative Michael Minick described the situation as walking on eggshells daily. This ongoing turmoil has contributed to a 29% decline in Tesla's share value this year, with a $224 billion loss in market capitalization.

FDIS

Read More

Cannabis Chart Of The Week: Are Ancillary Sectors Participating In The Rescheduling Price Upswing?

The graph depicts the stock price performance of baskets of stocks in six different cannabis industry subsectors. Each basket consists of the top four or five U.S. companies in each group. The stocks in each basket are equally weighted, and the basket prices are indexed so that August 25, 2023 (the Friday before the HHS announcement) equals 100.

AFCG

Read More

Google’s $1.1B Boost For Finnish AI Data Center: Details

Alphabet Inc's Google will invest an additional €1 billion in its Finland data center campus to enhance AI capabilities in Europe. This investment supports Google's commitment to sustainable technology, leveraging Finland's renewable energy. The Hamina facility, operating with 97% carbon-free energy, will also boost local employment and contribute excess heat to the community's district heating network, benefiting public infrastructure.

GOOGL

Read More

Atara Biotherapeutics Submits Tabelecleucel BLA For Treatment Of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease With U.S. FDA; Acceptance Of BLA Will Trigger $20M Milestone Payment From Pierre Fabre Laboratories, With Potential…

First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug AdministrationIf Approved, Tab-cel Would be First Approved Therapy in U.S. for EBV+ PTLDAcceptance of BLA Will Trigger $20 Million Milestone Payment

ATRA